Dr. Singal on the Importance of Early Diagnosis in HCC

Video

Amit G. Singal, MD, discusses the importance of early diagnosis for patients with hepatocellular carcinoma.

Amit G. Singal, MD, associate professor, UT Southwestern Medical Center, discusses the importance of early diagnosis for patients with hepatocellular carcinoma (HCC).

There have been several advances with locoregional and systemic therapies in HCC, says Singal. However, early identification and diagnosis remains a key component in the management of these patients.

Patients with early-stage HCC should be referred to a transplant center to determine whether or not they are eligible for surgical resection or liver transplant, explains Singal.

Though checkpoint inhibitors have improved survival for patients, they are associated with a risk of transplant rejection, says Singal. As such, transplant eligibility should be determined before beginning systemic therapy, concludes Singal.

Related Videos
Video 6 - "Patient Case 2: A 62-Year-Old Woman with Metastatic Rectal Cancer"
Video 5 - "Adverse Events Associated With TAS-102 Plus Bevacizumab in CRC"
Michael J. Overman, MD
Ilyas Sahin, assistant professor, Medicine, Department of Medicine, Division of Hematology & Oncology, University of Florida College of Medicine
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Eric S. Christenson, MD
Michael J. Overman, MD
Samer A. Srour, MB ChB, MS
Rebecca L. Porter, MD, PhD
Deborah J. Wong, MD, PhD